Snapshot

DOI:

Continue learning with EuroIntervention!

With the excitement of EuroPCR now in the past – and it was a wonderful moment to reconnect with colleagues and learn together – we move forward with thoughtful, original research on topics encompassing devices, techniques and, of course, the well- being of our patients.

Short DAPT after NSTE-ACS in HBR patients

Davide Cao, Roxana Mehran and colleagues compare the impact of 1 versus 3 months of dual antiplatelet therapy on the clinical outcomes of high bleeding risk patients undergoing percutaneous coronary intervention (PCI) due to non-ST-segment elevation acute coronary syndrome or chronic coronary syndrome. In their findings, a very short duration of dual antiplatelet therapy appears to be a valid bleeding avoidance strategy for these patients.

Early discharge after large-bore CTO PCI

Same-day discharge can augment patient comfort and decrease economic costs, but is this a feasible and safe practice for patients undergoing large-bore chronic total occlusion PCI? Yvemarie B.O. Somsen, Paul Knaapen and colleagues examine a CTO PCI registry and find that same-day discharge was achieved successfully in over 60% of patients, with low rates of overall vascular access complications.

Impact of calcium morphologies on IVL efficacy

Although calcium modification is recommended before stenting, do different calcium morphologies impact the efficacy of intravascular lithotripsy? Angela McInerney, Nieves Gonzalo and colleagues use optical coherence tomography to assess final stent parameters in patients undergoing intravascular lithotripsy for the treatment of calcified coronary artery disease.

Ultrathin-strut versus thin-strut BP-SES: healing and outcomes

Ryutaro Ikegami, Farouc A. Jaffer and colleagues study how the strut thickness of ultrathin-strut versus thin-strut biodegradable-polymer sirolimus-eluting stents impacts vessel healing and clinical outcomes at 30 days and 1 year. Given that the clinical outcomes were similar, they postulate that the benefits of biodegradable-polymer sirolimus-eluting stents may be independent of the strut thickness.

Volume 20 Number 10
May 20, 2024
Volume 20 Number 10
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00453 Jul 6, 2026
AnchorMan versus Watchman 2.5: a randomised comparison in left atrial appendage closure
Garot P and Nielsen-Kudsk J
free

Editorial

10.4244/EIJ-E-26-00011 Jul 6, 2026
Comparing transcatheter aortic valves: time to look beyond simplistic categorisations
Blackman D and Maznyczka A
free

Original Research

10.4244/EIJ-D-26-00158 Jul 6, 2026
Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trial
Fontana G et al

Research Correspondence

10.4244/EIJ-D-26-00315 Jul 6, 2026
Validation of the VARC-HBR consensus for defining high bleeding risk in TAVI
Singh M et al

Research Correspondence

10.4244/EIJ-D-26-00271 Jul 6, 2026
Outcomes of percutaneous mechanical aspiration in left-sided infective endocarditis
Lugo-Fagundo NS et al

Flashlight

10.4244/EIJ-D-26-00128 Jul 6, 2026
Concomitant transfemoral aortic and mitral valve replacement
Lianos I et al
Trending articles
334.7

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
45.75

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
29.2

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
29.2

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved